Bodybuilding Supplement Recall: Products Contained Undeclared Drug

A recall has been issued for a class of bodybuilding supplements that illegally use estrogen-inhibiting drugs, which may cause liver problems and unexpected aggressive behavior, according to federal health regulators. 

The FDA announced a dietary supplement recall for several different bodybuilding products, including:

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The FDA has determined that all of the recalled bodybuilding supplements use aromatase inhibitors, which is a controlled drug under the purview of FDA. The products were all being marketed as dietary supplements, which do not require FDA approval because they are not supposed to contain any controlled drugs and are not marketed to treat a disease.

Aromatase inhibitors block the development of estrogen, and are generally used to slow the growth of breast cancer tumors. The FDA warned that the side effects of aromatase inhibitors can include decreased bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure and liver dysfunction. People with liver, kidney, adrenal or prostate problems are at a higher risk of aromatase inhibitor side effects.

The FDA has determined that the recalled products have a “reasonable probability” of causing permanent injury to at-risk consumers. The agency recommends that any consumers that still have these drugs should stop using them immediately. They should contact a physician if they believe they have experienced any adverse side effects from taking the drugs.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.